| Altered profile of human gut microbiome is associated with cirrhosis and its complications JS Bajaj, DM Heuman, PB Hylemon, AJ Sanyal, MB White, P Monteith, ... Journal of hepatology 60 (5), 940-947, 2014 | 1055 | 2014 |
| Modulation of the fecal bile acid profile by gut microbiota in cirrhosis G Kakiyama, WM Pandak, PM Gillevet, PB Hylemon, DM Heuman, ... Journal of hepatology 58 (5), 949-955, 2013 | 754 | 2013 |
| Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation JS Bajaj, PB Hylemon, JM Ridlon, DM Heuman, K Daita, MB White, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 303 (6 …, 2012 | 597 | 2012 |
| A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer A Asgharpour, SC Cazanave, T Pacana, M Seneshaw, R Vincent, ... Journal of hepatology 65 (3), 579-588, 2016 | 497 | 2016 |
| Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy JS Bajaj, DM Heuman, AJ Sanyal, PB Hylemon, RK Sterling, RT Stravitz, ... PloS one 8 (4), e60042, 2013 | 477 | 2013 |
| The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids P Puri, K Daita, A Joyce, F Mirshahi, PK Santhekadur, S Cazanave, ... Hepatology 67 (2), 534-548, 2018 | 354 | 2018 |
| Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy JS Bajaj, NS Betrapally, PB Hylemon, DM Heuman, K Daita, MB White, ... Hepatology 62 (4), 1260-1271, 2015 | 322 | 2015 |
| Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis JS Bajaj, DM Heuman, PB Hylemon, AJ Sanyal, P Puri, RK Sterling, ... Alimentary pharmacology & therapeutics 39 (10), 1113-1125, 2014 | 319 | 2014 |
| Impaired gut-liver-brain axis in patients with cirrhosis V Ahluwalia, NS Betrapally, PB Hylemon, MB White, PM Gillevet, ... Scientific reports 6 (1), 26800, 2016 | 211 | 2016 |
| Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function JS Bajaj, IJ Cox, NS Betrapally, DM Heuman, ML Schubert, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (10 …, 2014 | 148 | 2014 |
| Preserved hemostatic status in patients with non-alcoholic fatty liver disease W Potze, MS Siddiqui, SL Boyett, J Adelmeijer, K Daita, AJ Sanyal, ... Journal of hepatology 65 (5), 980-987, 2016 | 94 | 2016 |
| Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus JS Bajaj, NS Betrapally, PB Hylemon, LR Thacker, K Daita, DJ Kang, ... Scientific reports 5 (1), 18559, 2015 | 85 | 2015 |
| An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis YI Luo, A Oseini, R Gagnon, ED Charles, K Sidik, R Vincent, R Collen, ... Scientific reports 8 (1), 12414, 2018 | 65 | 2018 |
| HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients JS Bajaj, RK Sterling, NS Betrapally, DE Nixon, M Fuchs, K Daita, ... Alimentary pharmacology & therapeutics 44 (6), 638-643, 2016 | 64 | 2016 |
| Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese [S] P Puri, J Xu, T Vihervaara, R Katainen, K Ekroos, K Daita, HK Min, ... Journal of lipid research 57 (6), 1017-1028, 2016 | 27 | 2016 |
| Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease S Bos, W Potze, MS Siddiqui, SL Boyett, J Adelmeijer, K Daita, T Lisman, ... Thrombosis Research 150, 41-43, 2017 | 5 | 2017 |
| Fast and simplified method for high through-put isolation of mirna from highly purified high density lipoprotein M Seneshaw, F Mirshahi, HK Min, A Asgharpour, S Mirshahi, K Daita, ... JoVE (Journal of Visualized Experiments), e54257, 2016 | 3 | 2016 |
| Improvement of fibrosis is associated with the decrease of collagen III formation biomarker Pro-C3 in patients with non-alcoholic steatohepatitis Y Luo, R Vincent, RC Gagnon, ED Charles, A Oseini, F Mirshahi, ... Hepatology 66, 345A-345A, 2017 | 2 | 2017 |
| Collagen formation and degradation biomarkers identify advanced fibrosis in NASH patients Y Luo, ED Charles, R Vincent, R Gagnon, A Oseini, B Banini, F Mirshahi, ... Journal of Hepatology 1 (66), S676-S677, 2017 | 2 | 2017 |
| Innovative and emerging technologies in GI physiology and disease: systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota … JS Bajaj, IJ Cox, NS Betrapally, DM Heuman, ML Schubert, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (10 …, 2014 | 2 | 2014 |
Patrick GillevetProfessor and Director, Microbiome Analysis Center, George Mason UniversityVerified email at gmu.edu
